Developing Story: From CLEOPATRA to Life on Enhertu – HER2+ MBC with Dr. Erika Hamilton & Dr. Sarah Premji
Clinical Trials, Treatment Decisions, Expert Interviews, Cancer Biology, Patient Education, Hope and Survivorship, Living with MBC, Patient Empowerment, FDA LiveFromStage4 Podcast Clinical Trials, Treatment Decisions, Expert Interviews, Cancer Biology, Patient Education, Hope and Survivorship, Living with MBC, Patient Empowerment, FDA LiveFromStage4 Podcast

Developing Story: From CLEOPATRA to Life on Enhertu – HER2+ MBC with Dr. Erika Hamilton & Dr. Sarah Premji

wenty-five years ago, HER2-positive breast cancer meant a two-year death sentence. Today, patients are living 12+ years on first-line treatment—and some are being cured.

In this deep dive, host Victoria Goldberg (living with metastatic HER2+ cancer for 12 years) and leading oncologists Dr. Erika Hamilton and Dr. Sarah Premji unpack the drugs, trials, and real-world strategies transforming one of cancer's most feared diagnoses into its greatest success story.

From CLEOPATRA's game-changing 16-month survival boost to antibody-drug conjugates that deliver chemotherapy straight to cancer cells, learn how precision medicine is rewriting the rules—and what patients need to know about side effects, sequencing, and hope.

Read More